July 2021 Price Concessions: 2nd Update
THIS CONTENT HAS NOW EXPIRED
The Department of Health and Social Care (DHSC) has today granted the following list of price concessions:
Drug | Pack Size | Price Concession |
Baclofen 10mg tablets | 84 | £3.30 |
Loratadine 5mg/5ml oral solution | 100ml | £7.75 |
Mebeverine 135mg tablets | 100 | £4.40 |
Pregabalin 100mg capsules | 84 | £5.42 |
Tolbutamide 500mg tablets | 28 | £16.79 |
Trimethoprim 50mg/5ml oral suspension sugar free | 100ml | £11.94 |
Ursodeoxycholic acid 250mg capsules | 60 | £11.98 |
The DHSC previously announced (14.07.2021) the following list of price concessions:
Drug | Pack Size | Price Concession |
Eplerenone 25mg tablets | 28 | £11.95 |
Eplerenone 50mg tablets | 28 | £15.53 |
Etoricoxib 60mg tablets | 28 | £6.00 |
Etoricoxib 90mg tablets | 28 | £8.35 |
Naftidrofuryl 100mg capsules | 84 | £7.84 |
Olmesartan medoxomil 20mg tablets | 28 | £6.44 |
Olmesartan medoxomil 40mg tablets | 28 | £10.35 |
Pregabalin 75mg capsules | 56 | £4.18 |
Sodium fluoride 0.05% mouthwash sugar free | 250ml | £1.74 |
Sulfasalazine 500mg gastro-resistant tablets | 112 | £17.52 |
Sulfasalazine 500mg tablets | 112 | £16.50 |
A price concession only applies for the month in which it is granted. No additional endorsements are required for price concessions.
PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated July 2021 Drug Tariff price. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from the DHSC.
If you have problems obtaining a Part VIII product at the stated Drug Tariff price, please report the issue using the online feedback form on the PSNC website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Contractors will be alerted to further updates to the price concession list through our website and via our e-news email. If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made.